Substance Abuse Research Alliance (SARA) is a program within the Georgia Prevention Project. Launching in April of 2016, SARA initiated the “White Paper” study as the organization’s first collaborative project with the primary goal of assisting the Georgia State Senate Study Committee on their Opioids and Heroin work and research. Since its first project, SARA has continued to expand and evaluate its efforts, as demonstrated in our quarterly meetings and annual Scorecards and collaborative GDPH Strategic Plan Reports.
With over 200 participants, SARA includes researchers, practitioners and public health advocates with a wide spectrum of experience in substance use disorder (SUD) work.
2017 legislative session: Georgia House Bill 249
The Georgia General Assembly and changes to Prescription Drug Monitoring Programs
Effective July 1, 2017, dispensers will be required to enter prescription information for Schedule II, III, IV, V controlled substances within 24 hours. This will provide prescribers more efficient access to information with less wait time as they make the best clinical decisions possible for their patients.
All prescribers will be required to register in the PDMP by Jan. 1, 2018. Currently only about 10 percent of prescribers in Georgia are registered in the PDMP. Prescribers already registered DO NOT need to re-register.
Beginning July 1, 2018, prescribers will be required to check PDMP before prescribing opiates or cocaine derivatives in Schedule II drugs or benzodiazepines. (Prescribers are currently encouraged to check the PDMP but are not yet required to do so.)
To find additional opioid-related legislative updates check out the Georgia General Assembly database